title: [Stimulating glutamatergic neurons as a potential novel therapeutic avenue for schizophrenia].
authors.affiliation: kazuhiro.nakato@jp.astellas.com
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Nakato
authors.forename: Katsuya
authors.initials: K
authors.lastname: Harada
authors.forename: Takahiko
authors.initials: T
authors.lastname: Tobe
authors.forename: Takayuki
authors.initials: T
authors.lastname: Yamaji
authors.forename: Shoji
authors.initials: S
authors.lastname: Takakura
mesh_terms: D000818:Animals; D015195:Drug Design; D005971:Glutamates / Q000032:analysis*; D005998:Glycine / Q000378:metabolism; D006801:Humans; D009474:Neurons / Q000737:chemistry*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D012521:Sarcosine / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D005971:Glutamates; D016194:Receptors, N-Methyl-D-Aspartate; D005998:Glycine; D012521:Sarcosine